Contact
Contact page
Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.23
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
61 / 100 · ready · see similar
AI training policy
allowed
AI-bot protection
AI files
Evidence
llms.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
PT-141 (Bremelanotide): What the Approved-Population Research Shows
Description
PT-141 (bremelanotide) is a melanocortin MC4R agonist approved for one use: HSDD in premenopausal women. A cited reading of the mechanism, the trials, and the honest tolerability cost.
Final URL
Language
en (html)
Scanned at
2026-06-26 05:24:01